<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Blachly PG</submitter><funding>Howard Hughes Medical Institute</funding><funding>NIGMS NIH HHS</funding><funding>PHS HHS</funding><pagination>e1003395</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3868525</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(12)</volume><pubmed_abstract>The nonmevalonate pathway is responsible for isoprenoid production in microbes, including H. pylori, M. tuberculosis and P. falciparum, but is nonexistent in humans, thus providing a desirable route for antibacterial and antimalarial drug discovery. We coordinate a structural study of IspH, a [4Fe-4S] protein responsible for converting HMBPP to IPP and DMAPP in the ultimate step in the nonmevalonate pathway. By performing accelerated molecular dynamics simulations on both substrate-free and HMBPP-bound [Fe4S4](2+) IspH, we elucidate how substrate binding alters the dynamics of the protein. Using principal component analysis, we note that while substrate-free IspH samples various open and closed conformations, the closed conformation observed experimentally for HMBPP-bound IspH is inaccessi</pubmed_abstract><journal>PLoS computational biology</journal><pubmed_title>Utilizing a dynamical description of IspH to aid in the development of novel antimicrobial drugs.</pubmed_title><pmcid>PMC3868525</pmcid><funding_grant_id>NIHGM31749</funding_grant_id><funding_grant_id>T32 GM008326</funding_grant_id><pubmed_authors>Blachly PG</pubmed_authors><pubmed_authors>McCammon JA</pubmed_authors><pubmed_authors>Williams SL</pubmed_authors><pubmed_authors>de Oliveira CA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Utilizing a dynamical description of IspH to aid in the development of novel antimicrobial drugs.</name><description>The nonmevalonate pathway is responsible for isoprenoid production in microbes, including H. pylori, M. tuberculosis and P. falciparum, but is nonexistent in humans, thus providing a desirable route for antibacterial and antimalarial drug discovery. We coordinate a structural study of IspH, a [4Fe-4S] protein responsible for converting HMBPP to IPP and DMAPP in the ultimate step in the nonmevalonate pathway. By performing accelerated molecular dynamics simulations on both substrate-free and HMBPP-bound [Fe4S4](2+) IspH, we elucidate how substrate binding alters the dynamics of the protein. Using principal component analysis, we note that while substrate-free IspH samples various open and closed conformations, the closed conformation observed experimentally for HMBPP-bound IspH is inaccessi</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013</publication><modification>2026-04-14T17:16:03.174Z</modification><creation>2019-03-27T01:18:45Z</creation></dates><accession>S-EPMC3868525</accession><cross_references><pubmed>24367248</pubmed><doi>10.1371/journal.pcbi.1003395</doi></cross_references></HashMap>